Markel Co. (NYSE:MKL) Vice Chairman Steven A. Markel sold 200 shares of the company’s stock in a transaction dated Thursday, January 4th. The stock was sold at an average price of $1,115.78, for a total value of $223,156.00. Following the transaction, the insider now directly owns 106,712 shares of the company’s stock, valued at $119,067,115.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Shares of Markel Co. (MKL) traded down $1.04 during midday trading on Friday, reaching $1,117.33. The company had a trading volume of 27,370 shares, compared to its average volume of 36,868. Markel Co. has a 1 year low of $612.00 and a 1 year high of $1,157.30. The company has a quick ratio of 0.55, a current ratio of 0.55 and a debt-to-equity ratio of 0.28. The firm has a market capitalization of $15,480.00, a PE ratio of 248.85 and a beta of 1.04.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Toronto Dominion Bank boosted its position in Markel by 11.0% during the second quarter. Toronto Dominion Bank now owns 171 shares of the insurance provider’s stock valued at $167,000 after purchasing an additional 17 shares during the last quarter. First Capital Advisors Group LLC. acquired a new position in Markel during the third quarter valued at approximately $202,000. Klingenstein Fields & Co. LLC acquired a new position in Markel during the third quarter valued at approximately $214,000. Sigma Investment Counselors Inc. acquired a new position in Markel during the third quarter valued at approximately $214,000. Finally, Athena Capital Advisors LLC acquired a new position in Markel during the third quarter valued at approximately $214,000. 76.79% of the stock is owned by hedge funds and other institutional investors.

Several research analysts have recently weighed in on MKL shares. Royal Bank of Canada reaffirmed a “hold” rating and set a $1,050.00 price objective on shares of Markel in a research report on Tuesday, October 3rd. Zacks Investment Research cut Markel from a “buy” rating to a “hold” rating in a research report on Tuesday, October 3rd. Boenning Scattergood reissued a “buy” rating on shares of Markel in a research report on Thursday, October 26th. Finally, SunTrust Banks reissued a “hold” rating and set a $1,100.00 price target on shares of Markel in a research report on Friday, October 27th. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Markel has an average rating of “Buy” and a consensus target price of $1,113.25.

TRADEMARK VIOLATION NOTICE: This article was first published by American Banking News and is the property of of American Banking News. If you are accessing this article on another publication, it was illegally stolen and republished in violation of US and international trademark and copyright legislation. The original version of this article can be viewed at https://www.americanbankingnews.com/2018/01/05/insider-selling-markel-co-mkl-vice-chairman-sells-200-shares-of-stock-2.html.

Markel Company Profile

Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.

Insider Buying and Selling by Quarter for Markel (NYSE:MKL)

Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.